Effects of bDMARDs on quality of life in patients with psoriatic arthritis: meta-analysis.

ABSTRACT:

Objectives

To determine the effects of biological disease-modifying anti-rheumatic drugs (bDMARDs) on the quality of life (QoL) among patients with psoriatic arthritis (PsA).

Design

Meta-analysis.

Data sources and eligibility criteria

PubMed, Web of Science, Cochrane Library, China National Knowledge Infrastructure, WanFang and VIP databases were searched to collect randomised controlled trials (RCTs), which were conducted to evaluate the effect of bDMARDs in the treatment of patients with PsA and reported QoL-related outcomes, from inception to November 2020 and updated on 19 February 2022.

Data extraction and synthesis

Outcomes about Health Assessment Questionnaire Disability Index (HAQ-DI), Dermatology Life Quality Index, physical component summary and menta

SUBMITTER: Lu Y 

PROVIDER: S-EPMC9006847 | biostudies-literature | 2022 Apr

REPOSITORIES: biostudies-literature